Enochian Biosciences, Inc. ENOB
0.71 0.00 (+0.00%)
Aug 4, 2023, 3:58 PM EDT
0.70 Day range 0.745
0.393 52-week range 2.99
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
3 Doomed Biotech Stocks Destined for Disaster The world of biotech stocks is notoriously difficult to predict. History is littered with companies that appeared destined for superstar status only to crash and burn.
benzinga.com Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday.
benzinga.com Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Session Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 32 companies reached new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning session, 137 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 75 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 49 companies made new 52-week lows.
headlinesoftoday.com ENOB FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action – ENOB NEW YORK, Sept. 14, 2022 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) between January 17,…
headlinesoftoday.com ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ENOB NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) between January 17, 2018 and June…- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 539 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 319 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 588 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 340 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 87 companies hit new 52-week lows.
- benzinga.com This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
- benzinga.com 62 Biggest Movers From Yesterday Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.
benzinga.com 'Murder-For-Hire Conspiracy': Why Enochian Biosciences Stock Is Plunging Enochian Biosciences Inc (NASDAQ: ENOB) shares are trading lower Wednesday after Hindenburg Research issued a bearish report on the company. Last week, federal prosecutors announced the arrest of two…- benzinga.com 70 Biggest Movers From Friday Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for…
investorplace.com ENOB Stock Gains 20% Following Founder Arrest, Hindenburg Short Enochian Bioscience is in the green today following the shocking arrest of the company founder earlier this week. ENOB stock closed up 20%.
benzinga.com 6 Stocks Halted In Wednesday's Session: Here's Why A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and…
pulse2.com ENOB Stock: Why The Price Increased Today The stock price of Enochian Biosciences Inc (NASDAQ: ENOB) increased by over 3% pre-market today. This is why it happened.
globenewswire.com Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month Company encouraged by clear path to IND in near-term following its review of the FDA's Center for Biologics Evaluation and Research written comments Company encouraged by clear path to IND in…
globenewswire.com Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity LOS ANGELES, Oct. 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced…
globenewswire.com Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today…
globenewswire.com Enochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection Company encouraged by clear path following review of FDA's CBER written comments Company encouraged by clear path following review of FDA's CBER written comments
globenewswire.com Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences' Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants LOS ANGELES, Aug. 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene-modified cellular and immune therapies for infectious diseases and cancer, announced…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers MorphoSys (NASDAQ:MOR) stock moved upwards by 15.07% to $16.26 during Thursday's after-market session. The market value of their outstanding shares is at $2.2 billion.
globenewswire.com Distinguished Scientific and Clinical Leader to Join Enochian BioSciences' Hepatitis B Cure Scientific Advisory Board LOS ANGELES, Aug. 23, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced…
globenewswire.com Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer Dr. Dybul's Deep and Prestigious Scientific Research Expertise Helps to Affirm Enochian BioSciences' Scientific Approach Dr. Dybul's Deep and Prestigious Scientific Research Expertise Helps to Affirm…
benzinga.com Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program Enochian BioSciences Inc (NASDAQ: ENOB) has announced that the FDA has accepted a Pre-IND (Investigational New Drug) request for a potential cure of hepatitis B virus (HBV) infection. Written…
globenewswire.com Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection LOS ANGELES, July 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today…
globenewswire.com Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today…
seekingalpha.com Enochian Biosciences: A Follow Through For An HIV Cure Enochian Biosciences: A Follow Through For An HIV Cure
fool.com Why Enochian BioSciences Was a Winner on Monday The company scores an exclusive license for new potential coronavirus treatment technology.
benzinga.com Enochian BioSciences Stock Is Trading Higher After In-Licensing COVID-19, Influenza Inhaled Treatment Technology Enochian BioSciences Inc (NASDAQ: ENOB) has acquired an exclusive license for a technology to potentially treat and prevent all variants of coronavirus, including the cause of COVID-19, as well as…- benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning session, 255 companies made new 52-week highs.
benzinga.com 90 Biggest Movers From Yesterday Gainers- benzinga.com 95 Biggest Movers From Yesterday Gainers Extraction Oil & Gas, Inc. (NASDAQ: XOG) shares climbed 247.9% to close at $1.48 on Monday following a 53% gain on Friday. The OPEC+ agreed to extend production cuts into July.
benzinga.com 71 Stocks Moving In Monday's Mid-Day Session Gainers Extraction Oil & Gas, Inc. (NASDAQ: XOG) shares jumped 177.4% to $1.18 following a 53% gain on Friday. The OPEC+ agreed to extend production cuts into July.- benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning trading, 98 companies set new 52-week highs.
- benzinga.com 60 Biggest Movers From Yesterday Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares surged 71.1% to close at $15.21 on Thursday after the company announced it has received FDA emergency use authorization for its coronavirus…
- benzinga.com 84 Biggest Movers From Yesterday Gainers
- benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday
- benzinga.com 52 Biggest Movers From Wednesday
- benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com 42 Biggest Movers From Yesterday